2. Bridging the Financial Gap to Global Immunization
Biopharmaceutical company PnuVax is particular about addressing the needs of the developing
countries. PnuVax continues to be at the forefront of developing and producing vaccines on a
worldwide scale.
3. Bridging the Financial Gap to Global Immunization
The World Health Organization (WHO) has reported that the cost to develop a new vaccine is
estimated at $500 million. WHO also reported that on average, the entire process of vaccine
development would take up to 15 years or even more.
4. Bridging the Financial Gap to Global Immunization
Decision-makers and donors have seriously considered this gap and have implemented innovative
funding solutions to leverage available resources for vaccination strategies. Three innovative
funding solutions are currently being implemented to continue the significant contribution of
immunization to public health. They are the International Finance Facility for Immunization (IFFIm),
the Advance Market Commitments (AMCs), and the UNITAID.
5. Bridging the Financial Gap to Global Immunization
Launched in 2006, IFFIm purchases vaccines using large sums of money through legal
agreements to pay from donor countries. Through these agreements, IFFIm issues bonds and are
sold in the international capital market while the donors guarantee future payments to bondholders.
The proceeds of the sale of bonds are used to fund immunization programs.
6. Bridging the Financial Gap to Global Immunization
Meanwhile, AMCs use agreements made by donor countries that provide a guarantee that in the
event that in the future a new vaccine is developed that would prevent a particular disease, the
donor countries will purchase a predetermined volume at an agreed-upon price. The agreements
also guarantee the safety and efficacy standards that the new vaccine should meet so that
pharmaceutical companies can compete for the production of the new vaccine.
7. Bridging the Financial Gap to Global Immunization
Under the UNITAID, participating countries levy structured taxes on airline tickets. The proceeds
go to a fund administered by the WHO, which will be used to purchase drugs against malaria,
tuberculosis, and AIDS.